XML 57 R31.htm IDEA: XBRL DOCUMENT v3.3.1.900
Segment Information (Tables)
6 Months Ended
Dec. 31, 2015
Segment Reporting Information [Line Items]  
Revenue by Reportable Segment
The following tables present revenue for each reportable segment and Corporate:
 
Three Months Ended December 31
(in millions)
2015
 
2014
Pharmaceutical
$
28,287

 
$
22,627

Medical
3,162

 
2,914

Total segment revenue
31,449

 
25,541

Corporate (1)
(4
)
 
(4
)
Total revenue
$
31,445

 
$
25,537


 
Six Months Ended December 31
(in millions)
2015
 
2014
Pharmaceutical
$
53,427

 
$
43,836

Medical
6,081

 
5,766

Total segment revenue
59,508

 
49,602

Corporate (1)
(9
)
 
5

Total revenue
$
59,499

 
$
49,607


(1)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following tables present segment profit by reportable segment and Corporate:
 
Three Months Ended December 31
(in millions)
2015
 
2014
Pharmaceutical
$
627

 
$
542

Medical
106

 
115

Total segment profit
733

 
657

Corporate
(170
)
 
(111
)
Total operating earnings
$
563

 
$
546


 
Six Months Ended December 31
(in millions)
2015
 
2014
Pharmaceutical
$
1,285

 
$
992

Medical
207

 
229

Total segment profit
1,492

 
1,221

Corporate
(309
)
 
(209
)
Total operating earnings
$
1,183

 
$
1,012

Assets by Reportable Segment
The following table presents total assets for each reportable segment and Corporate at:
(in millions)
December 31,
2015
 
June 30,
2015
Pharmaceutical
$
20,464

 
$
17,385

Medical
9,741

 
7,095

Corporate
3,302

 
5,662

Total assets
$
33,507

 
$
30,142